Australia Gastric Cancer Diagnostics Market to 2032
Overview
The Australia Gastric Cancer Diagnostics Market is expected to reach a 44.25 USD Million by 2032 and is projected to grow at a CAGR of 12.82% from 2025 to 2032.
Revenue, 2024 (USD Million)
22.50
Forecast, 2032 (USD Million)
44.25
CAGR, 2024 - 2032
12.82%
Report Coverage
Australia
Australia Gastric Cancer Diagnostics Market 2018-2032 USD Million
Australia Gastric Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 22.50 USD Million
- Projected Market Size (2032): 44.25 USD Million
- CAGR (2025-2032): 12.82%
Key Findings of Australia Gastric Cancer Diagnostics Market
- The Australia Gastric Cancer Diagnostics Market was valued at 22.50 USD Million in 2024.
- The Australia Gastric Cancer Diagnostics Market is likely to grow at a CAGR of 12.82% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 14.31 USD Million
- The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 15.94% during the forecast period from 2024 to 2032.
Australia Gastric Cancer Diagnostics Market Scope
Australia Gastric Cancer Diagnostics Market Segmentation & Scope
Product Type
- Services
- Instruments
- Reagents & Consumables
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Gender
- Female
- Male
Sample Type
- Urine
- Blood
- Tissue
- Stool
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Age Group
- Pediatric
- Adult
- Geriatrics
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Australia Gastric Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 22.50 USD Million |
| Market Value in 2032 | 44.25 USD Million |
| CAGR (2025-2032) | 12.82% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Distribution Channel,Age Group,Disease Type |
Regional Insights:
-
Leading Market (2024-2032): Australia, leading in terms of revenue 22.50 USD Million in 2024
- Key Country: Australia, leading in terms of revenue with value of 22.50 USD Million in 2024.
Segments and Scope
-
Australia Gastric Cancer Diagnostics Market to 2032, By Product Type
- Reagents & Consumables is the largest segment in Australia Gastric Cancer Diagnostics Market to 2032 with a revenue of 12.52 USD Million in the year 2024.
- Reagents & Consumables is the Fastest growing segment in Australia Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 14.79 % in forecast period 2025-2032.
-
Australia Gastric Cancer Diagnostics Market to 2032, By Diagnostic Type
- Confirmatory Test is the largest segment in Australia Gastric Cancer Diagnostics Market to 2032 with a revenue of 13.02 USD Million in the year 2024.
- Confirmatory Test is the Fastest growing segment in Australia Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.85 % in forecast period 2025-2032.
-
Australia Gastric Cancer Diagnostics Market to 2032, By Stage
- Stage I is the largest segment in Australia Gastric Cancer Diagnostics Market to 2032 with a revenue of 8.57 USD Million in the year 2024.
- Stage I is the Fastest growing segment in Australia Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.31 % in forecast period 2025-2032.
-
Australia Gastric Cancer Diagnostics Market to 2032, By Gender
- Male is the largest segment in Australia Gastric Cancer Diagnostics Market to 2032 with a revenue of 12.09 USD Million in the year 2024.
- Male is the Fastest growing segment in Australia Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.73 % in forecast period 2025-2032.
-
Australia Gastric Cancer Diagnostics Market to 2032, By Sample Type
- Stool is the largest segment in Australia Gastric Cancer Diagnostics Market to 2032 with a revenue of 9.28 USD Million in the year 2024.
- Stool is the Fastest growing segment in Australia Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.81 % in forecast period 2025-2032.
-
Australia Gastric Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Australia Gastric Cancer Diagnostics Market to 2032 with a revenue of 7.83 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Australia Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.94 % in forecast period 2025-2032.
-
Australia Gastric Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Australia Gastric Cancer Diagnostics Market to 2032 with a revenue of 14.31 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Australia Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 13.83 % in forecast period 2025-2032.
-
Australia Gastric Cancer Diagnostics Market to 2032, By Age Group
- Geriatrics is the largest segment in Australia Gastric Cancer Diagnostics Market to 2032 with a revenue of 12.10 USD Million in the year 2024.
- Geriatrics is the Fastest growing segment in Australia Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.07 % in forecast period 2025-2032.
-
Australia Gastric Cancer Diagnostics Market to 2032, By Disease Type
- Intestinal or Diffuse Adinocarcinoma is the largest segment in Australia Gastric Cancer Diagnostics Market to 2032 with a revenue of 10.03 USD Million in the year 2024.
- Intestinal or Diffuse Adinocarcinoma is the Fastest growing segment in Australia Gastric Cancer Diagnostics Market to 2032 with a Growth rate of 15.32 % in forecast period 2025-2032.
Australia Gastric Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| BIOMÉRIEUX | |||
| Abbott | |||
| General Electric | |||
| F. Hoffmann-La Roche Ltd. | |||
Australia Gastric Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Australia Gastric Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Australia Gastric Cancer Diagnostics Market is segmented based on Segmentation Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Distribution Channel,Age Group,Disease Type.
Australia Gastric Cancer Diagnostics Market was valued at USD 22.50(Revenue in USD Million) in 2020.
Australia Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 12.82% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the Australia Gastric Cancer Diagnostics Market, holding a largest market share of 14.31 USD Million in 2024
Australia Gastric Cancer Diagnostics Market Scope
Australia Gastric Cancer Diagnostics Market Segmentation & Scope
Product Type
- Services
- Instruments
- Reagents & Consumables
Diagnostic Type
- Gastric Cancer Screening Tests/Physical Exam
- Confirmatory Test
Stage
- Stage 0
- Stage III
- Stage II
- Stage I
Gender
- Female
- Male
Sample Type
- Urine
- Blood
- Tissue
- Stool
End User
- Others
- Oncology Speciality Clinics
- Cancer Research Institutes
- Diagnostic Laboratories
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Age Group
- Pediatric
- Adult
- Geriatrics
Disease Type
- Others
- Gastric Lymphoma
- Gastrointestinal Stromal Tumor
- Carcinoid tumor
- Intestinal or Diffuse Adinocarcinoma
Frequently Asked Questions
The Australia Gastric Cancer Diagnostics Market is segmented based on Segmentation Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Distribution Channel,Age Group,Disease Type.
Australia Gastric Cancer Diagnostics Market was valued at USD 22.50(Revenue in USD Million) in 2020.
Australia Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 12.82% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Gastric Cancer Diagnostics Market for final year is USD 44.25 (USD Million).
Australia Gastric Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The Australia Gastric Cancer Diagnostics Market is segmented based on Segmentation Product Type,Diagnostic Type,Stage,Gender,Sample Type,End User,Distribution Channel,Age Group,Disease Type.
Australia Gastric Cancer Diagnostics Market was valued at USD 22.50(Revenue in USD Million) in 2020.
Australia Gastric Cancer Diagnostics Market is projected to grow at a CAGR of 12.82% during the forecast period of 2024 to 2032.
The estimated market value of the Australia Gastric Cancer Diagnostics Market for final year is USD 44.25 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.